|Trial Design||Non-controlled trial|
|Trial Length||1-6 months|
|Number of Subjects||12|
|Age Range||45-64, 65+|
12 weeks supplementation of oxiracetam (400mg for 4 weeks, building up to 1,200mg for 4 weeks) was able to provide a modest improvement on clinical ratings of cognition by about 1 point (on a 5 point scale) and seemed to favor verbal improvements.